Skip to main content

atg5 deficiency mouse

Atg5 缺失可加重动脉粥样硬化斑块形成,用于研究自噬对巨噬细胞稳态与病变进展的影响。

Outcome measures

获得可用于兔主动脉斑块组织学分级和组成的 HE 染色切片。

Experimental animals

动脉组织石蜡切片 H&E 染色
Age
不限(固定组织切片)
Tissue
动脉组织

Experimental procedures

H&E staining **Dewaxing:** Paraffin sections are placed in xylene for 3 x 00:03:00 H&E staining **Rehydration: ** Paraffin sections are placed in - 100% EtOH for 3 x 00:03:00 - 95% EtOH for 1 x 00:03:00 - Rinse with water H&E staining **Hematoxylin staining: ** Paraffin sections are stained with hematoxylin for 00:00:20 and rinse under running water for 00:01:00 H&E staining **Differentiation and bluing:** Paraffin sections are placed into the bluing reagent for 00:01:00 and rinse under running water for 00:01:00 _This step results in a blue coloration of the nuclei._ H&E staining **Eosin staining:** Parrafin sections are counterstained with Eosin for 00:00:10 _This step results in a pink coloration of the cytoplasmic components and connective tissue fibers._ H&E staining **Dehydration and Clearing:** Paraffin sections are placed in - 95% EtOH for 00:02:00 - 100% EtOH for 2 x 00:02:00 - Xylene for 2 x 00:02:00 H&E staining **Mounting:** Parrafin sections are mounted with a glass coverslip using Permount.

Model identity

Model name
atg5 deficiency mouse
Species
mouse
Genotype / zygosity
ATG5-deficient

Experimental methods

Experimental protocols

  • 动脉组织石蜡切片 H&E 染色

    Hematoxylin and eosin staining of paraffin arterial sections for histological morphology.

    • This protocol's applicability to this model

      Status:Verified applicability· Evidence type:Literature evidence· Source:https://pubmed.ncbi.nlm.nih.gov/32411803/ ; https://doi.org/10.17504/protocols.io.kxygxr9jdg8j/v1 ; Applicability inference for arterial paraffin histology; not claimed as the original paper execution of this exact protocol version.

      Age:不限(固定组织切片)Tissue:动脉组织

      动脉病变组织形态评估。

Reagents and materials

References

  1. Macrophage-Based Therapies for Atherosclerosis Management Journal of Immunology Research 2020 PMID:32411803
  2. Macrophage-Based Therapies for Atherosclerosis Management PMID:32411803
  3. protocols.io · v1 · Nathalia L. Oliveira; samantha.gruenheid · This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
  4. ARRIVE 2.0 guidelines